Invo Bioscience Inc   (INVO)
Other Ticker:  
Price: $1.2100 $0.06 5.217%
Day's High: $1.22 Week Perf: 6.14 %
Day's Low: $ 1.16 30 Day Perf: 21 %
Volume (M): 26 52 Wk High: $ 7.20
Volume (M$): $ 31 52 Wk Avg: $0.94
Open: $1.19 52 Wk Low: $0.12

 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 2
 Employees -
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Invo Bioscience Inc
Invo Bioscience Inc is a medical device company that specializes in infertility treatments. The company developed a unique device called the INVOcell, which is an FDA-approved intravaginal culture system used in the process of in vitro fertilization (IVF). The INVOcell eliminates the need for expensive laboratory equipment and provides a more natural incubation process for embryos. Invo Bioscience aims to make fertility treatments more accessible and affordable to a larger population.

   Company Address: 5582 Broadcast Court Sarasota 34240 FL
   Company Phone Number: 878-9505   Stock Exchange / Ticker: NASDAQ INVO
   INVO is expected to report next financial results on April 16, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Invo Bioscience Inc

INVO's Revenue Soars, Yet Profitability Remains Elusive

Invo Bioscience Inc, a medical equipment and supplies company, has recently announced impressive revenue growth in its most recent fiscal period. The company's revenue rose by a staggering 314.283% year on year to $0.97 million. However, it is worth noting that the company also experienced expanded losses of $-0.70.
Despite these losses, Invo Bioscience Inc has outperformed its industry competitors in terms of revenue growth. While the rest of the Medical Equipment & Supplies industry cited a 4.83% revenue rise during the same period, Invo Bioscience Inc more than doubled this growth with a 208.606% increase from $0.32 million.

Invo Bioscience Inc

Invo Bioscience Inc Shatters Industry Norms with Astonishing 116% Revenue Growth ? Financial Results Unveiled

As an investor closely following the financial sector, it is always intriguing to analyze and interpret the financial results of various companies. In this article, we will analyze the recent financial results of INVO Bioscience Inc and discuss its implications.
INVO Bioscience Inc announced an impressive 116.171% year-on-year revenue growth, amounting to $0.32 million in the financial interval ending June 30, 2023. However, the company also experienced an increased shortfall per share at $-3.06. Despite this shortfall, INVO Bioscience Inc has outperformed its industry contemporaries, as the Medical Equipment & Supplies industry only witnessed a 3.96% revenue growth during the same period.

Invo Bioscience Inc

A Wake-Up Call for Healthcare Investors in Q1 2023

Invo Bioscience Inc is a company in the Healthcare sector that recorded a cumulative net loss of $-11 million during the 12 months ending in the first quarter of 2023. This has resulted in a negative return on investment (ROI) of -404.22%. This means that for every dollar invested in the company, there was a net loss of $4.04.
During the same period, 804 other companies in the Healthcare sector had a higher ROI than Invo Bioscience Inc, indicating that the company's performance is relatively poor compared to its peers.


Invo Bioscience Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com